Mui Uyen Ngoc, Haley Christopher T, Tyring Stephen K
Center for Clinical Studies, Houston, TX 77004, USA.
Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX 77004, USA.
J Clin Med. 2017 Nov 29;6(12):111. doi: 10.3390/jcm6120111.
Oncoviruses are implicated in approximately 12% of all human cancers. A large number of the world's population harbors at least one of these oncoviruses, but only a small proportion of these individuals go on to develop cancer. The interplay between host and viral factors is a complex process that works together to create a microenvironment conducive to oncogenesis. In this review, the molecular biology and oncogenic pathways of established human oncoviruses will be discussed. Currently, there are seven recognized human oncoviruses, which include Epstein-Barr Virus (EBV), Human Papillomavirus (HPV), Hepatitis B and C viruses (HBV and HCV), Human T-cell lymphotropic virus-1 (HTLV-1), Human Herpesvirus-8 (HHV-8), and Merkel Cell Polyomavirus (MCPyV). Available and emerging therapies for these oncoviruses will be mentioned.
致癌病毒约占所有人类癌症的12%。世界上大量人口至少携带一种此类致癌病毒,但只有一小部分人会患上癌症。宿主因素和病毒因素之间的相互作用是一个复杂的过程,共同作用以创造有利于肿瘤发生的微环境。在本综述中,将讨论已确定的人类致癌病毒的分子生物学和致癌途径。目前,有七种公认的人类致癌病毒,包括爱泼斯坦-巴尔病毒(EBV)、人乳头瘤病毒(HPV)、乙型和丙型肝炎病毒(HBV和HCV)、人类嗜T淋巴细胞病毒1型(HTLV-1)、人类疱疹病毒8型(HHV-8)和默克尔细胞多瘤病毒(MCPyV)。还将提及针对这些致癌病毒的现有和新兴疗法。